Black Nightshade — Hermetica Encyclopedia
Herb · African

Black Nightshade (Solanum nigrum)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Black nightshade contains steroidal alkaloids—solamargine (C₄₅H₇₃NO₁₅) and solasonine (C₄₅H₇₃NO₁₆)—alongside flavonoids quercetin and kaempferol that collectively inhibit lipid peroxidation via arachidonate-5-lipoxygenase suppression and upregulate hepatic antioxidant enzymes superoxide dismutase and catalase. In a controlled rat liver-injury model, fruit extract normalized serum AST from 241.6 IU/L toward control values, elevated SOD from 4.9 to 7.2 U/mg, and raised CAT from 64.1 to 74.4 U/mg, demonstrating measurable hepatoprotective and antioxidant activity at the preclinical level.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordblack nightshade benefits
Black Nightshade close-up macro showing natural texture and detail — rich in catalase, bax/bcl-2 ratio shift), liver
Black Nightshade — botanical close-up

Health Benefits

**Hepatoprotection**
Fruit extracts containing solamargine and phenolic compounds significantly reduced elevated liver enzymes (AST, ALT, alkaline phosphatase) and restored albumin levels in rat models of chemically induced liver injury, suggesting a cytoprotective and antioxidant-mediated mechanism.
**Anti-inflammatory and Pain Relief**
Steroidal alkaloids and flavonoids inhibit pro-inflammatory lipid mediator pathways, consistent with Kenyan and pan-African ethnobotanical use of leaf poultices and decoctions for arthralgia, headache, and topical wound pain.
**Antioxidant Activity**
Total phenolic content of 76–109 mg GAE/g and proanthocyanidin levels of 332–890 mg CE/g (in Algerian fruit extracts) confer substantial free-radical scavenging capacity, with quercetin and kaempferol binding cytochrome c peroxidase (PDB: 2x08) to suppress oxidative tissue damage.
**Antitumor Properties**
Solamargine and solasonine exhibit in vitro cytotoxicity against gastric, lung, liver, prostate, and melanoma cell lines, likely through membrane disruption and apoptosis induction, though these findings remain confined to cell-culture systems without human trial validation.
**Skin Disorder Management**
Traditional Kenyan preparations of crushed leaves applied topically address eczema, boils, and inflammatory dermatoses; bioactive alkaloids and tannins (30–97 mg TE/g) are posited to reduce local inflammation and inhibit cutaneous pathogens.
**Neuroprotective Effects**
Solasodine (C₂₇H₄₃NO₂) has demonstrated anticonvulsant activity in preclinical models, and phenolic antioxidants may attenuate neuronal oxidative stress, supporting traditional use for fever-associated neurological symptoms.
**Immunomodulatory Activity**: Polysaccharide fractions isolated from S
nigrum are reported to enhance macrophage activation and modulate innate immune responses in animal studies, suggesting adjunctive potential in immune-supportive ethnomedicinal applications.

Origin & History

Black Nightshade growing in Africa — natural habitat
Natural habitat

Solanum nigrum is a cosmopolitan weed native to Eurasia that has naturalized across sub-Saharan Africa, including Kenya, where it thrives in disturbed soils, moist roadsides, and cultivated fields at elevations ranging from sea level to approximately 2,400 meters. In East Africa, it is cultivated semi-intentionally as a leafy vegetable and medicinal plant, often harvested wild from garden margins and fallowed agricultural land. The plant grows as an annual or short-lived perennial herb reaching 30–90 cm in height, producing small white stellate flowers and clusters of green-to-black berries upon maturity.

Solanum nigrum has been documented in traditional medicine systems across millennia: in Ayurveda it is known as Makoi (Hindi) or Munatakali (Telugu) and is included in classical texts as a hepatoprotective and antipyretic herb, while in traditional Chinese medicine the whole plant (Long Kui) has been employed for detoxification and tumor management since at least the Tang Dynasty (618–907 CE). In Kenyan and broader East African ethnobotany, black nightshade—locally called managu among the Kikuyu—occupies a dual role as a staple leafy vegetable and a medicinal plant applied in poultice form to wounds, skin infections, and painful joints, with preparations passed through generations of community healers and smallholder farmers. European herbalists of the medieval period cautiously referenced the plant as a soporific and topical analgesic, though its toxicological reputation in the West limited widespread adoption. The plant's global distribution and its appearance in the ethnopharmacopeias of over 40 countries across Africa, Asia, and the Americas reflects convergent recognition of its therapeutic utility, making it one of the most cross-culturally documented medicinal weeds in the world.Traditional Medicine

Scientific Research

The current body of evidence for Solanum nigrum is composed almost entirely of in vitro cell-line assays and small-scale in vivo animal experiments, with no published randomized controlled trials in humans identified in the peer-reviewed literature as of 2024. The most quantitatively detailed preclinical study employed a Sprague-Dawley rat liver-injury model with four experimental groups, demonstrating statistically significant reductions in AST (from 241.6 IU/L to near-control values), ALT from 108.8 IU/L, and alkaline phosphatase from 645.6 to 547.5 IU/L alongside increases in SOD (4.9 to 7.2 U/mg) and CAT (64.1 to 74.4 U/mg); however, group sizes were not fully disclosed, limiting statistical power assessment. Antitumor data derive from cancer cell-line cytotoxicity screens showing activity of solamargine and solasonine against multiple tumor types, but without pharmacokinetic data in humans or dose-escalation safety studies these findings cannot be translated directly to clinical recommendations. Phytochemical characterization studies—primarily from Algerian and Asian samples—provide robust quantification of phenolic, flavonoid, tannin, and alkaloid content, but geographic and ecotypic variation in bioactive concentrations means that standardization across commercial or therapeutic preparations remains an unresolved challenge.

Preparation & Dosage

Black Nightshade prepared as liquid extract — pairs with Solanum nigrum's flavonoid fraction—particularly quercetin and kaempferol—may exhibit additive antioxidant synergy when combined with other polyphenol-rich botanicals such as turmeric (Curcuma longa), as both curcumin and S. nigrum flavonoids independently suppress lipoxygenase and COX-mediated inflammatory pathways, potentially broadening anti-inflammatory coverage through complementary enzyme inhibition. Traditional
Traditional preparation
**Traditional Leaf Decoction (Kenya/East Africa)**
20–50 g) boiled in 500 mL water for 15–20 minutes, strained, and consumed as 1–2 cups daily for pain or inflammation; no standardized dose established
Fresh leaves (.
**Ethanolic Fruit Extract (Research Form)**
200–400 mg/kg body weight in animal models; human equivalent doses have not been calculated or validated
Used in preclinical hepatoprotection studies; concentrations typically .
**Topical Leaf Poultice**
Fresh crushed leaves applied directly to affected skin areas for boils, eczema, and localized pain; frequency and duration vary by tradition.
**Whole Berry (Food Use)**
Ripe black berries consumed in small amounts as a food source across Africa and Asia; quantities not standardized medicinally and glycoalkaloid content necessitates caution with large intakes.
**Crude Aqueous or Hydroalcoholic Extract**
Available in some regional herbal markets; standardization for alkaloid or flavonoid content is not currently established by any pharmacopeial authority.
**Standardization Note**
No international standard for solamargine, solasonine, or total alkaloid content exists for commercial preparations; consumers should exercise caution with any product claiming standardization without third-party verification.

Nutritional Profile

Solanum nigrum leaves provide meaningful concentrations of vitamin C (approximately 27–47 mg/100 g in fruit, likely higher in fresh leaves), contributing to dietary antioxidant intake across food-insecure East African populations. Phytochemically, fruit extracts demonstrate total phenolic content of 76–109 mg GAE/g dry weight, total flavonoid content of 22–88 mg CE/g, tannins at 30–97 mg TE/g, and exceptionally high proanthocyanidins at 332–890 mg CE/g, placing the fruit among the more phenolic-dense wild African botanicals. Steroidal alkaloids (solamargine, solasonine, solasodine) constitute approximately 27–51% of alkaloid fractions in some analyses, alongside steroidal saponins and polysaccharides. Bioavailability of alkaloids and phenolics from whole plant material is likely reduced by co-occurring tannins that bind proteins and polyphenols in the gastrointestinal tract, while lipid co-ingestion may enhance absorption of lipophilic steroidal compounds; formal bioavailability studies in humans are absent.

How It Works

Mechanism of Action

The steroidal alkaloids solamargine and solasonine intercalate into cholesterol-rich membrane domains of cancer cells, disrupting membrane integrity and triggering intrinsic apoptotic cascades, though the precise receptor-level targets in human tissue remain under active investigation. Flavonoids quercetin and kaempferol act as competitive inhibitors of arachidonate-5-lipoxygenase (PDB: 6n2w) and bind cytochrome c peroxidase (PDB: 2x08), thereby suppressing eicosanoid-driven inflammation and reducing lipid hydroperoxide accumulation in hepatic and peripheral tissues. At the enzyme level, S. nigrum fruit extracts upregulate superoxide dismutase and catalase activity—key components of the endogenous antioxidant defense system—reducing reactive oxygen species load and protecting against oxidative hepatocellular injury as evidenced by normalized transaminase and alkaline phosphatase levels in rat models. Tannins and proanthocyanidins additionally contribute astringent and antimicrobial effects at mucosal and skin surfaces through protein precipitation and bacterial membrane destabilization, underpinning topical ethnobotanical applications.

Clinical Evidence

No human clinical trials evaluating Solanum nigrum for pain relief, skin disorders, hepatoprotection, or antitumor activity have been published with sufficient methodological rigor to establish clinical efficacy or safe dosing parameters. The most structured available evidence is a rat hepatotoxicity model in which ethanolic fruit extract meaningfully restored liver enzyme profiles and antioxidant enzyme activity, but the absence of dose-response curves and full statistical reporting constrains confidence in translational inference. Antitumor outcomes reported in cell-line studies—while mechanistically plausible—represent the lowest tier of oncological evidence and should not be extrapolated to patient management without corroborating in vivo and eventually phase I/II human data. Overall, clinical confidence in S. nigrum remains low; the ingredient sits firmly in the preclinical evidence stage, warranting properly designed safety and efficacy trials before therapeutic claims can be substantiated.

Safety & Interactions

Solanum nigrum contains glycoalkaloids—including solamargine and solasonine—at concentrations that may reach toxic thresholds with excessive consumption; related complex member Solanum scabrum berries have been measured at up to 1,500 mg total glycoalkaloids per fruit batch, and acute glycoalkaloid toxicity can manifest as nausea, vomiting, abdominal cramping, and neurological symptoms including drowsiness and confusion. No formal maximum tolerated dose or no-observed-adverse-effect level (NOAEL) has been established for human supplemental use, and preclinical studies showing no acute toxicity with standardized extracts do not rule out chronic or high-dose risk. The herb's capacity to modulate liver enzymes (AST, ALT, alkaline phosphatase) suggests a potential pharmacokinetic interaction risk with hepatotoxic medications, drugs with narrow therapeutic indices metabolized by CYP450 enzymes, and anticonvulsants given solasodine's anticonvulsant activity. Pregnant and lactating individuals should avoid medicinal doses due to the complete absence of reproductive safety data and the known biological activity of steroidal alkaloids on hormonal pathways; topical use of leaf preparations at low frequency is considered lower risk but remains unstudied in clinical populations.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Solanum nigrumGarden NightshadeMakoiManaguMunatakaliLong KuiCommon Nightshade

Frequently Asked Questions

Is black nightshade safe to eat or use medicinally?
Black nightshade contains steroidal glycoalkaloids—including solamargine and solasonine—that can be toxic in large amounts; related species have measured up to 1,500 mg glycoalkaloids per berry batch, which is well above safe thresholds. Ripe berries in small food quantities and briefly boiled leaves have a long history of consumption in East Africa, but no standardized safe supplemental dose has been established for humans, and medicinal extracts should be used with caution and ideally under professional guidance.
What does black nightshade do for the liver?
Preclinical rat studies found that Solanum nigrum fruit extract significantly reduced elevated liver enzymes—AST dropped from 241.6 IU/L toward control values and alkaline phosphatase fell from 645.6 to 547.5 IU/L—while simultaneously raising the antioxidant enzymes superoxide dismutase (from 4.9 to 7.2 U/mg) and catalase (from 64.1 to 74.4 U/mg). These hepatoprotective effects are attributed to phenolic antioxidants and steroidal alkaloids that reduce oxidative stress and protect hepatocyte membranes, though no human clinical trials have confirmed these findings.
How is black nightshade used traditionally in Kenya for pain and skin problems?
In Kenyan ethnomedicine, black nightshade leaves are typically crushed into a fresh poultice and applied directly to painful joints, boils, eczema, and infected skin lesions, with tannins (30–97 mg TE/g) and steroidal alkaloids providing local anti-inflammatory and antimicrobial effects. For internal pain or inflammation, a decoction of 20–50 g of fresh leaves boiled in water is consumed as 1–2 cups daily, a preparation consistent with anti-inflammatory use documented among Kikuyu communities in central Kenya.
Does black nightshade have anticancer properties?
In vitro laboratory studies have shown that the steroidal alkaloids solamargine and solasonine exhibit cytotoxicity against several cancer cell lines including gastric, lung, liver, prostate, and melanoma cells, likely through membrane disruption and apoptosis induction. However, these findings come exclusively from cell-culture experiments and have not been validated in human clinical trials or even robust animal tumor models with full pharmacokinetic data, meaning no anticancer claims can currently be made for human therapeutic use.
What are the main active compounds in black nightshade?
Solanum nigrum contains at least 188 identified chemicals, with the most pharmacologically active being the steroidal alkaloids solamargine (C₄₅H₇₃NO₁₅), solasonine (C₄₅H₇₃NO₁₆), and solasodine (C₂₇H₄₃NO₂), alongside flavonoids quercetin and kaempferol, proanthocyanidins (332–890 mg CE/g in fruit), tannins, and vitamin C. The alkaloids drive antitumor and anti-inflammatory activity, while quercetin and kaempferol provide antioxidant effects by inhibiting arachidonate-5-lipoxygenase and binding cytochrome c peroxidase.
What is the difference between black nightshade berries and leaves, and which form is more effective?
Black nightshade berries and leaves contain different concentrations of active compounds, with fruit extracts typically showing stronger hepatoprotective effects due to higher levels of solamargine and phenolic antioxidants. The berries are the traditionally consumed form and have been more extensively studied for liver and anti-inflammatory benefits, whereas leaves are sometimes used in traditional preparations but carry higher alkaloid concentrations that require careful dosing. Most clinical evidence supports the use of standardized fruit extracts rather than whole plant material for safety and efficacy.
Does black nightshade interact with liver medications or drugs that are metabolized by the liver?
Black nightshade's hepatoprotective compounds may theoretically affect liver enzyme activity, which could influence the metabolism of medications processed through cytochrome P450 pathways, though clinical interaction studies are limited. Anyone taking prescription medications for liver disease, immunosuppressants, or drugs with narrow therapeutic windows should consult a healthcare provider before using black nightshade supplements. The ingredient's steroidal alkaloids warrant particular caution when combined with drugs requiring hepatic metabolism.
What does current clinical research show about black nightshade's effectiveness compared to conventional anti-inflammatory supplements?
Animal studies demonstrate that black nightshade's steroidal alkaloids and flavonoids reduce inflammatory markers and pro-inflammatory cytokines with mechanisms similar to some conventional anti-inflammatories, though human clinical trials remain sparse and mostly conducted in African traditional medicine contexts. The evidence base is strongest for hepatoprotection and liver enzyme normalization in chemically induced injury models, with less robust data on pain relief compared to established NSAIDs or curcumin. Most existing research comes from in vitro and animal studies rather than large-scale human randomized controlled trials, limiting definitive efficacy claims.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.